Express Pharma - Page 447 of 2181 - Express Pharma

CuraTeQ Biologics reports Phase 3 results for BP11 biosimilar to Xolair

Bayer revises access model for Eylea 2mg in India to expand patient eligibility

Leading people in the age of AI

Indoco’s AnaCipher CRO clears US FDA inspection with Zero 483s

Bugworks Research and Cytecare Cancer Hospitals partner to accelerate development of immuno-oncology therapies

European Commission approves Roche’s Vabysmo to treat vision loss

Sandoz announces positive results for biosimilar Denosumab

EU recommends marketing approval for Evusheld to treat COVID-19

US FDA approves Bluebird Bio’s gene therapy for rare neurological disorder

Sitagliptin combinations for diabetics to be sold at JAKs

Mankind Pharma files DRHP with SEBI

Digitisation and data analytics critical to attain peak productivity

Zydus receives tentative approval from the US FDA for Sugammadex Injection